NAD Press Releases

NAD Examines Implied Claims for FIOS Quantum Following Cablevision Challenge

NAD has determined that Verizon Communications, Inc., has provided a reasonable basis for advertising claims that FiOS Quantum TV subscribers can record up to 12 shows at once, watch TV “on the go,” store up to 200 hours of HD programming, and watch recorded programming in other rooms.

Read More

NAD Finds Lifes2Good Can Support Certain Claims for the Company’s Viviscal Supplement; Recommends Advertiser Discontinue One Claim

NAD has determined that Lifes2Good, Inc., can support certain claims for the company’s Viviscal dietary supplement, a product promoted to women with thinning hair.

Read More

NAD Recommends Terra Novo Modify, Discontinue Certain Claims for Erosion Product; Finds Advertiser Can Support Certain Claims

The NAD has recommended that Terra Novo, Inc., modify or discontinue certain advertising claims for the company’s erosion control products. NAD determined, however, that the advertiser’s evidence served to support certain advertising claims.

Read More

NAD Recommends Novartis Discontinue Onset-of-Action Claim for Theraflu, following Pfizer Challenge

The NAD has recommended that Novartis Consumer Health Inc., discontinue the advertising claim that “Theraflu Multi-Symptom Severe Cold” “starts to get to work in your body in 5 minutes.” The claim was challenged by Pfizer Consumer Healthcare, a competing manufacturer of cold and cough relief products.

Read More

NAD Refers Advertising Claims from Cortec Corp. to FTC for Further Review

The NAD has referred to the FTC advertising claims made by Cortec Corporation, the maker of vapor corrosion inhibiting (VCI) products, after the advertiser declined to participate in a self-regulatory review of its advertising claims.

Read More

NAD Refers Advertising for Obesity Research Council’s ‘Lipozene’ to FTC for Review after Advertiser Declines to Participate in NAD Proceeding

NAD has referred advertising for Lipozene, a product marketed by the Obesity Research Council, to the Federal Trade Commission (FTC) after the company declined to participate in NAD’s review of its advertising claims.

Read More